HuGE Literature Finder
Records
1
-
5
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia. The New England journal of medicine 2019 8 381 (5): 432-443. Shanafelt Tait D, Wang Xin V, Kay Neil E, Hanson Curtis A, O'Brien Susan, Barrientos Jacqueline, Jelinek Diane F, Braggio Esteban, Leis Jose F, Zhang Cong C, Coutre Steven E, Barr Paul M, Cashen Amanda F, Mato Anthony R, Singh Avina K, Mullane Michael P, Little Richard F, Erba Harry, Stone Richard M, Litzow Mark, Tallman Mart |
The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia. Leukemia & lymphoma 2015 Mar 1-6. Grzywnowicz Maciej, Karabon Lidia, Karczmarczyk Agnieszka, Zajac Malgorzata, Skorka Katarzyna, Zaleska Joanna, Wlasiuk Paulina, Chocholska Sylwia, Tomczak Waldemar, Bojarska-Junak Agnieszka, Dmoszynska Anna, Frydecka Irena, Giannopoulos Krzyszt |
Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients. PloS one 2015 10 (3): e0121526. Rombout Ans, Stamatopoulos Basile, Lagneaux Laurence, Lust Sofie, Offner Fritz, Naessens Evelien, Vanderstraeten Hanne, Verhasselt Bruno, Philippé J |
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2012 Mar 97 (3): 437-41. Del Giudice Ilaria, Rossi Davide, Chiaretti Sabina, Marinelli Marilisa, Tavolaro Simona, Gabrielli Sara, Laurenti Luca, Marasca Roberto, Rasi Silvia, Fangazio Marco, Guarini Anna, Gaidano Gianluca, Foà Rob |
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia. British journal of haematology 2009 Jan 144 (2): 217-22. Pratt Guy, Harding Stephen, Holder Roger, Fegan Chris, Pepper Chris, Oscier David, Gardiner Anne, Bradwell Arthur R, Mead Grah |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: